There's a conversation happening in every commercial org right now. Leadership wants to know if AI can help the team move faster. Sales wants to know if it's going to replace them. Marketing is already using it to produce more content than anyone will ever read. And somewhere in the middle, a VP is on a stage talking about "the future of GTM" while their reps still can't articulate why their product is different from the competitor two spaces down.
Here's what I've seen after fifteen years in healthtech: AI isn't coming to rescue broken commercial organizations. It's coming to make the dysfunction undeniable.
That is not a warning. It's an opportunity if you're willing to look at what it's actually surfacing.
What AI Does to a Sales Org
When you layer AI onto a sales motion, automated sequencing, signal-based outreach, generative messaging, AI-assisted pipeline review, one thing happens immediately: volume goes up. Emails go out faster. Summaries get generated. Call notes appear without effort.
And then, if the underlying rigor isn't there, the cracks go wide.
Reps are sending more emails to people who were never good fits to begin with. The messaging is faster but no clearer because AI can't invent a compelling value proposition, it can only amplify the one you give it. If your value prop is vague, you now have a very efficient engine producing vague outreach at scale. The pipeline inflates. The conversion doesn't. And suddenly the problem that was easy to explain away, "we just need more activity", is impossible to hide.
In healthtech, I've watched this play out in market after market. Companies come in with a genuinely differentiated model, a telehealth platform with real clinical depth, a digital therapeutic with outcomes data, a DTP offering that actually removes friction for the patient, and they can't close at the rate the product deserves. Not because buyers aren't interested. Because the commercial motion isn't built on a clear enough understanding of who the ideal customer actually is, what their specific problem is, and why this solution closes that gap better than anything else they could buy or build.
AI doesn't solve that. It stress-tests it.
The ICP Problem
Ideal customer profile work is some of the least sexy and most consequential work in commercial strategy. Most organizations do it once, early, and then quietly stop updating it as the market evolves, the product expands, or the team turns over. It becomes a slide in an onboarding deck rather than a living foundation for how the team allocates energy.
When AI enters the picture, ICP clarity becomes your ceiling.
If you can give an AI system a precise description of your buyer, their role, their organization type, the signals that indicate they're in-market, the language they use to describe the problem you solve, you can build something that compounds. Every dollar of prospecting goes further. Every sequence lands with more relevance. Every rep starts the conversation closer to a yes.
If you can't? You're training the AI on noise. And it will learn to produce more of it, faster.
The companies I've seen genuinely win with AI in their commercial stack are the ones who had already done the uncomfortable work. They knew their ICP at a granular level. They knew which buyer personas drove deals and which ones stalled them. They had a point of view on why they won and why they lost not assumptions, not hunches, but real data reviewed with real honesty. AI gave them leverage on something that was already working.
Messaging Discipline Is the Other Gap
Here is the test: take your three strongest reps and ask them to explain your value proposition in their own words. Don't prime them. Just ask. If you get three meaningfully different answers, you don't have a messaging problem, you have a foundation problem.
AI can generate a hundred variations of your outreach. It cannot create alignment where there isn't any. The organizations that see the most lift from AI-assisted messaging are the ones that had already invested in defining a core message, testing it against real buyers, and building the kind of clarity that lets a rep internalize and deploy it without reading from a script.
That work is hard. It requires sales leadership and marketing to actually sit in the same room and look at lost deals together. It requires someone willing to say "our positioning isn't landing" before a board asks why the number isn't moving. In healthtech especially where buyers are sophisticated, procurement cycles are long, and the cost of a wrong investment is measured in patient outcomes and budget cycles, undisciplined messaging gets punished.
AI is going to make sure everyone sees the score.
What AI-Ready Actually Looks Like
An AI-ready commercial organization isn't defined by the tools it uses. It's defined by what it knows before it picks up the tool.
It has a documented ICP that gets reviewed and challenged quarterly. It has a value proposition that sales and marketing can both say out loud, to a real buyer, and have it land. It has pipeline hygiene not as a CRM checkbox exercise, but as a genuine practice of knowing what's real and what's wishful. It has a culture of reviewing losses as carefully as wins, because losses are where the signal lives.
When that foundation exists, AI is transformative. Genuinely. It takes a disciplined system and makes it faster, more consistent, and more scalable. It lets great reps focus their time on the conversations that actually require a human. The ones where trust is built, complexity gets worked through, and the buyer moves from interested to committed.
What it cannot do is substitute for the clarity that makes all of that possible.
The question for every commercial leader right now isn't "should we adopt AI?" That ship has sailed, and the answer is yes. The question is whether you've done the work that lets AI amplify you, or whether you're about to find out, at scale, what's actually been broken.
The tool will tell you. Make sure you're ready to hear the answer.